TC-S 7005 targets Polo-like kinases, which are essential regulators of cell division and mitosis, making them effective in halting the proliferation of cancer cells. It targets PLK1, PLK2, and PLK3.
Molecular Weight
359.38
Molecular Formula
C21H17N3O3
Targets
PLK1: 214 nM; PLK2: 4 nM; PLK3: 24 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
TC-S 7005 is employed to study its specific inhibition of VEGFR2 in angiogenesis research.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
